| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |